Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast
Read full show notes here: https://bit.ly/3r2hU9A
Subscribe to receive exclusive subscriber-only content: https://bit.ly/3r7TUSg
Sign up to receive Peter's email newsletter: https://bit.ly/3G1kr8n
Allan Sniderman is a highly acclaimed Professor of Cardiology and Medicine at McGill University and a foremost expert in cardiovascular disease (CVD). In this episode, Allan explains the many risk factors used to predict atherosclerosis, including triglycerides, cholesterol, and lipoproteins, and he makes the case for apoB as a superior metric that is currently being underutilized. Allan expresses his frustration with the current scientific climate and its emphasis on consensus and unanimity over encouraging multiple viewpoints, thus holding back the advancement of metrics like apoB for assessing CVD risk, treatment, and prevention strategies. Finally, Allan illuminates his research that led to his 30-year causal model of risk and explains the potentially life-saving advantages of early intervention for the prevention of future disease.
We discuss:
00:00:00 - Intro
00:00:10 - Problems with the current 10-year risk assessment of cardiovascular disease (CVD) and the implications for prevention
00:14:32 - A primer on cholesterol, apoB, and plasma lipoproteins
00:22:07 - Pathophysiology of CVD and the impact of particle cholesterol concentration vs. number of particles
00:28:45 - Limitations of standard blood panels
00:33:10 - Remnant type III hyperlipoproteinemia—high cholesterol, low Apo B, high triglyceride
00:39:26 - Using apoB to estimate risk of CVD
00:42:57 - How Mendelian randomization is bolstering the case for ApoB as the superior metric for risk prediction
00:53:47 - Hypertension and CVD risk
01:05:49 - Factors influencing the decision to begin preventative intervention for CVD
01:11:37 - Using the coronary artery calcium (CAC) score as a predictive tool
01:23:27 - The challenge of motivating individuals to take early interventions
01:26:30 - How medical advancement is hindered by the lack of critical thinking once a “consensus” is reached
01:33:24 - PSK9 inhibitors and familial hypercholesterolemia: two examples of complex topics with differing interpretations of the science
01:39:49 - Defining risk and uncertainty in the guidelines
01:46:07 - Making clinical decisions in the face of uncertainty
01:51:58 - How the emphasis on consensus and unanimity has become a crucial weakness for science and medicine
01:59:58 - Factors holding back the advancement of apoB for assessing CVD risk, treatment, and prevention strategies
02:11:44 - Advantages of a 30-year risk assessment and early intervention
--------
About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 35 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.
Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).
Learn more: https://bit.ly/3rbsBXk
Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG
Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle
Видео Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast канала Peter Attia MD
Subscribe to receive exclusive subscriber-only content: https://bit.ly/3r7TUSg
Sign up to receive Peter's email newsletter: https://bit.ly/3G1kr8n
Allan Sniderman is a highly acclaimed Professor of Cardiology and Medicine at McGill University and a foremost expert in cardiovascular disease (CVD). In this episode, Allan explains the many risk factors used to predict atherosclerosis, including triglycerides, cholesterol, and lipoproteins, and he makes the case for apoB as a superior metric that is currently being underutilized. Allan expresses his frustration with the current scientific climate and its emphasis on consensus and unanimity over encouraging multiple viewpoints, thus holding back the advancement of metrics like apoB for assessing CVD risk, treatment, and prevention strategies. Finally, Allan illuminates his research that led to his 30-year causal model of risk and explains the potentially life-saving advantages of early intervention for the prevention of future disease.
We discuss:
00:00:00 - Intro
00:00:10 - Problems with the current 10-year risk assessment of cardiovascular disease (CVD) and the implications for prevention
00:14:32 - A primer on cholesterol, apoB, and plasma lipoproteins
00:22:07 - Pathophysiology of CVD and the impact of particle cholesterol concentration vs. number of particles
00:28:45 - Limitations of standard blood panels
00:33:10 - Remnant type III hyperlipoproteinemia—high cholesterol, low Apo B, high triglyceride
00:39:26 - Using apoB to estimate risk of CVD
00:42:57 - How Mendelian randomization is bolstering the case for ApoB as the superior metric for risk prediction
00:53:47 - Hypertension and CVD risk
01:05:49 - Factors influencing the decision to begin preventative intervention for CVD
01:11:37 - Using the coronary artery calcium (CAC) score as a predictive tool
01:23:27 - The challenge of motivating individuals to take early interventions
01:26:30 - How medical advancement is hindered by the lack of critical thinking once a “consensus” is reached
01:33:24 - PSK9 inhibitors and familial hypercholesterolemia: two examples of complex topics with differing interpretations of the science
01:39:49 - Defining risk and uncertainty in the guidelines
01:46:07 - Making clinical decisions in the face of uncertainty
01:51:58 - How the emphasis on consensus and unanimity has become a crucial weakness for science and medicine
01:59:58 - Factors holding back the advancement of apoB for assessing CVD risk, treatment, and prevention strategies
02:11:44 - Advantages of a 30-year risk assessment and early intervention
--------
About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 35 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.
Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).
Learn more: https://bit.ly/3rbsBXk
Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG
Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle
Видео Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast канала Peter Attia MD
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![The importance of sleep for metabolic health ](https://i.ytimg.com/vi/TQ9-zuF_13A/default.jpg)
![Introduction to Egg Boxing | Peter Attia, M.D.](https://i.ytimg.com/vi/7S9m-ZVVgTU/default.jpg)
![Metabolic syndrome increases your risk of everything ](https://i.ytimg.com/vi/4-Q0-ckRHWk/default.jpg)
![Understanding and improving your metabolic health (AMA 51 Sneak Peek)](https://i.ytimg.com/vi/p8QCOK1ASuk/default.jpg)
![How to manage your wants | Peter Attia & Arthur Brooks](https://i.ytimg.com/vi/vjET-e7znQo/default.jpg)
![How to practically change your behaviors | Peter Attia & James Clear](https://i.ytimg.com/vi/eEJVZ4yqupg/default.jpg)
![Why we repeat bad habits | Peter Attia & James Clear](https://i.ytimg.com/vi/BhCfp9BZJKk/default.jpg)
![270 ‒ Journal club with Andrew Huberman: metformin, power of belief, & how to read scientific papers](https://i.ytimg.com/vi/boyTPdYJArs/default.jpg)
![How to train your cardiovascular fitness | Peter Attia](https://i.ytimg.com/vi/_8djNYprRDI/default.jpg)
![261 ‒ Training for The Centenarian Decathlon: zone 2, VO2 max, stability, and strength](https://i.ytimg.com/vi/NivjpZ0VBro/default.jpg)
![What drugs are available to treat low sexual desire in premenopausal women? | Peter Attia](https://i.ytimg.com/vi/_RSYjhHGzHE/default.jpg)
![Does testosterone therapy cause an increased risk of prostate cancer? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/EMVsNKRuMNQ/default.jpg)
![How common is sexual dysfunction in men? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/JKxLmRWLehE/default.jpg)
![What causes Peyronie's disease and what can be done to treat it? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/TVx2gXIpMt0/default.jpg)
![What are the medications available to treat low testosterone? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/n-HMke2QSbs/default.jpg)
![What causes premature ejaculation and what can be done to treat it? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/UJ0t3fxbhJA/default.jpg)
![Shockwave therapy, stem cell therapy, and platelet-rich plasma treatment for ED | Peter Attia](https://i.ytimg.com/vi/Jgtr96wlKRI/default.jpg)
![What causes erectile dysfunction and what can be done to treat it? | Peter Attia & Mohit Khera](https://i.ytimg.com/vi/14oX4-4Cnnc/default.jpg)
![260 ‒ Men’s Sexual Health: why it matters, what can go wrong, and how to fix it](https://i.ytimg.com/vi/GNCpG1fkMBA/default.jpg)
![What's the difference between sexual desire and arousal? | Peter Attia & Sharon Parish](https://i.ytimg.com/vi/yAmAmSyJNbY/default.jpg)
![How important is sexual health for overall well-being in women? | Peter Attia & Sharon Parish](https://i.ytimg.com/vi/piSJQNX7bFI/default.jpg)